Securities Purchase AgreementSecurities Purchase Agreement • August 9th, 2013 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 9th, 2013 Company Industry JurisdictionThis Securities Purchase Agreement (the “Agreement”) is made as of [ ], 2013 (the “Effective Date”) by and among Protea Biosciences Group, Inc., a Delaware corporation (the “Company”), and the undersigned purchaser (the “Purchaser”).
Warrant Purchase and Reimbursement AgreementSecurities Purchase Agreement • May 10th, 2013 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 10th, 2013 Company Industry JurisdictionThis Amended and Restated Securities Purchase Agreement (the “Agreement”) is made as of March 6, 2013 (the “Effective Date”) by and among Protea Biosciences Group, Inc., a Delaware corporation (the “Company”), and Steven Antoline (the “Purchaser”).
Securities Purchase AgreementSecurities Purchase Agreement • May 10th, 2013 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 10th, 2013 Company Industry JurisdictionThis Securities Purchase Agreement (the “Agreement”) is made as of [ ], 2013 (the “Effective Date”) by and among Protea Biosciences Group, Inc., a Delaware corporation (the “Company”), and the undersigned purchaser (the “Purchaser”).
Securities Purchase AgreementSecurities Purchase Agreement • March 27th, 2013 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 27th, 2013 Company Industry JurisdictionThis Securities Purchase Agreement (the “Agreement”) is made as of March 21, 2013 (the “Effective Date”) by and among Protea Biosciences Group, Inc., a Delaware corporation (the “Company”), and the undersigned purchaser (the “Purchaser”).
Securities Purchase AgreementSecurities Purchase Agreement • January 24th, 2013 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 24th, 2013 Company Industry JurisdictionThis Securities Purchase Agreement (the “Agreement”) is made as of November 20, 2012 (the “Effective Date”) by and among Protea Biosciences Group, Inc., a Delaware corporation (the “Company”), and the undersigned purchaser (the “Purchaser”).
Amended and Restated Securities Purchase AgreementSecurities Purchase Agreement • January 24th, 2013 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 24th, 2013 Company Industry JurisdictionThis Amended and Restated Securities Purchase Agreement (the “Agreement”) is made as of [________] (the “Effective Date”) by and among Protea Biosciences Group, Inc., a Delaware corporation (the “Company”), and the undersigned purchaser (the “Purchaser”).